Evidence map›Paper›PMID 19307731›Full record

ArticleThe Journal of clinical investigation2009

Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis.

Maria Galluzzo, Selma Pennacchietti, Stefania Rosano, Paolo M Comoglio, Paolo Michieli

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The draft genome of the blood pheasant (Ecology and evolution · 2020
    Article
  13. Review
  14. Pancreatic cancer stroma: an update on therapeutic targeting strategies.Nature reviews. Gastroenterology & hepatology · 2020
    Review
  15. Article
  16. The role of myoglobin in epithelial cancers: Insights from transcriptomics.International journal of molecular medicine · 2020
    Article
  17. Article
  18. Article
  19. Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth.Journal of experimental & clinical cancer research : CR · 2016
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maria GalluzzoLaboratory of Experimental Therapy, Institute for Cancer Research and Treatment, University of Turin Medical School, Turin, Italy.
Selma Pennacchietti
Stefania Rosano
Paolo M Comoglio
Paolo Michieli
Candiolo Cancer Institute · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a tumor grows, it requires increased amounts of oxygen. However, the tumor blood vessels that form to meet this demand are functionally impaired, leading to regions of hypoxia within the tumor. Such hypoxia is one of the hallmarks of malignancy and is thought to promote a number of tumorigenic properties. Here, we sought to determine how tumors without hypoxia would progress by engineering A549 human lung carcinoma cells to ectopically express myoglobin (Mb), a multifunctional heme protein that specializes in oxygen transport, storage, and buffering. Mb expression prevented the hypoxic response in vitro and delayed tumor engraftment and reduced tumor growth following xenotransplantation into mice. Experimental tumors expressing Mb displayed reduced or no hypoxia, minimal HIF-1alpha levels, and a homogeneously low vessel density. Mb-mediated tumor oxygenation promoted differentiation of cancer cells and suppressed both local and distal metastatic spreading. These effects were primarily due to reduced tumor hypoxia, because they were not observed using point-mutated forms of myoglobin unable to bind oxygen and they were abrogated by expression of a constitutively active form of HIF-1alpha. Although limited to xenograft models, these data provide experimental proof of the concept that hypoxia is not just a side effect of deregulated growth but a key factor on which the tumor relies in order to promote its own expansion.

Indexed as

Amino Acid SequenceAnimalsBase SequenceCell DeathCell DifferentiationCell HypoxiaCell Line, TumorCell ProliferationDNA PrimersFemaleGene ExpressionHumansHypoxia-Inducible Factor 1, alpha SubunitMiceMice, NudeMolecular Sequence DataDNA PrimersHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitMyoglobinOxygenRecombinant Proteins

Identifiers

PMID19307731
PMCPMC2662552
OpenAlexW2132635696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.